Furthermore, the global oncology/cancer drugs market growth is propelled by surge in geriatric population, increase in collaboration between pharmaceutical companies for development of novel cancer drugs, and rise in awareness associated with early detection of cancer among populace.
Tag Archives: drugs
Oncology/Cancer Drugs Market Expected to reach $274.40 Billion by 2030 | By Allied Market Research
North America accounted for the largest share of revenue in 2020, and is anticipated to maintain its dominance from 2021 to 2030, owing to presence of large patient population, strong presence of key players, ease of drug availability.
Global HIV Drugs Market is Projected to Reach $36.49 Billion by 2027 | Says Allied Market Research
The global HIV drugs market accounted for $30.89 billion in 2019, and is expected to reach $36.49 billion by 2027, registering a CAGR of 3.8% from 2020 to 2027.
Oncology-Cancer Drugs Market | Industry, Revenue & Trends Analysis From 2021 To 2030
The global oncology drugs market size was valued at $135,494.17 million in 2020, and is projected to reach $274,400.63 million by 2030, registering a CAGR of 7.5% from 2021 to 2030.
Asthma and COPD Drugs Market 2022 | Asia-Pacific is anticipated to grow at a CAGR of 6% rate during the analysis period
Asthma and COPD Drugs Market by Diseases (Asthma and COPD) and Medication Class (Combination Drugs, Inhaled Corticosteroids (ICS), Short Acting Beta Agonists (SABA), Long Acting Beta Agonists (LABA), Leukotriene Antagonists (LTA), Anticholinergics, and Others.): Global Opportunity Analysis and Industry Forecast, 2021––2030 The global Asthma and COPD Drugs Market Size was valued at $32988.7 million in 2020 …